CALR and neoplasm: found that CRT produced by exon 9 mutation of the CALR gene can inhibit the phagocytosis of dendritic cells (DCS) to dying cancer cells, thus reducing the effectiveness of tumor immunotherapy by chemotherapeutic drugs or PD-1 blockade (179).